The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2021, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).
The House Appropriations Committee released the FY 2023 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill on June 23, 2022 and accompanying report on June 29, 2022. The Labor HHS appropriations bill includes funding for U.S. global health programs provided to the Centers for Disease Control and Prevention (CDC) and funding for global health research activities provided to the National Institutes of Health (NIH). Total global health funding at CDC…
As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
The House Committee on Appropriations released its FY 2023 State, Foreign Operations, and Related Programs (SFOPs) appropriations bill on June 21, 2022 and accompanying report on June 28, 2022. The SFOPs bill includes funding for U.S. global health programs at the State Department and the U.S. Agency for International Development (USAID). Funding for these programs, through the Global Health Programs (GHP) account, which represents the bulk of global health assistance, totaled nearly $11 billion, an…
This analysis assesses the association between PEPFAR investments and maternal and child health outcomes. It finds that the program was associated with significant, positive improvement maternal and child health, adding to the evidence base that PEPFAR has had positive health spillover effects beyond just HIV.
In 2020, only 25% of people who could benefit from pre-exposure prophylaxis (PrEP), a medication that reduces the risk of acquiring HIV, were prescribed it. Using telehealth to provide PrEP, “tele-PrEP,” is a new approach that shows potential for expanding access to PrEP use in the United States that predates the COVID-19 pandemic. A new KFF analysis takes a deep dive into the tele-PrEP landscape, from the types of providers offering the service to the…
President Biden released the FY 2023 budget request to Congress on March 28, 2022. The request includes discretionary funding for U.S. global health programs at the State Department, the U.S. Agency for International Development (USAID), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). In addition, the request includes newly proposed mandatory funding for pandemic preparedness activities. Key highlights for the known amounts are as follows (see tables for…
This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.
With funding for additional COVID-19 support at a stalemate in Congress, a new KFF analysis looks at potential scenarios that United States might face if a 4th COVID-19 vaccine dose is recommended to the public. The analysis finds that the U.S. government does not have enough funding to purchase vaccine doses remaining to fully cover the population under any of the predicted scenarios. If 4th doses are authorized and recommended for all ages, there will…
This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.
© 2026 KFF